The Immunology Podcast cover image

IMMUNOLOGY2024™: Day 4

The Immunology Podcast

00:00

Advancements in TIL Therapy and Vaccine-Prime T Cell Research

This chapter highlights a successful phase two trial of tumor-infiltrating lymphocyte therapy for metastatic melanoma, which achieved a 31% response rate and prompted FDA acceleration. It also discusses future trials, the integration of PD-1 inhibitors, and innovative vaccination strategies to enhance adoptive immunotherapy.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app